Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.2010
+0.0082 (4.25%)
Jun 24, 2026, 5:29 PM CET
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 135.21 million as of June 24, 2026. Its market cap has decreased by -9.02% in one year.
Market Cap
135.21M
Enterprise Value
79.60M
Revenue
920.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 135.21M, a decrease of -68.15%. That is a compound annual growth rate of -10.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 135.21M | -11.45% |
| Dec 30, 2025 | 152.70M | 64.79% |
| Dec 30, 2024 | 92.66M | 15.47% |
| Dec 29, 2023 | 80.25M | -86.52% |
| Dec 30, 2022 | 595.21M | -64.93% |
| Dec 30, 2021 | 1.70B | -37.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 161.30B |
| Sectra AB | 54.18B |
| Getinge AB | 53.44B |
| Medicover AB | 33.05B |
| iZafe Group AB | 155.01M |
| Active Biotech AB | 148.15M |
| Nosa Plugs AB | 136.07M |
| Boule Diagnostics AB | 134.36M |